Future talent to secure firm’s continued success
Property developer and investor Howard Group has outlined its new five-year strategy for sustaining future growth following a period of significant reshaping within its property business.
New collaboration helps prepare students for a future in chemistry
Cambridge Regional College and the Royal Society of Chemistry have signed a new collaboration, agreeing to work together to support the development of the chemical sciences in further education.
Registration opens for OpenPlant Forum in Cambridge
Registration is now open for OpenPlant Forum, an annual open meeting for plant synthetic biology organised by the OpenPlant partners: University of Cambridge, John Innes Centre and the Earlham Institute. Attendees from other organisations are welcome to the event, which takes place in Cambridge from 24-26 July 2017.
King’s College Chapel, 21 pianos, one very special performance
One of the UK’s most iconic buildings will resonate to the sound of 21 pianos tomorrow (Tuesday) evening as part of a unique event involving a Cambridge composer, students and young musicians from around Cambridgeshire.
Cambridge Regional College in UK education mission to Guatemala
Cambridge Regional College’s international education experts have been in Guatemala as part of a UK mission to strengthen English language and technical skills-based education in the country.
OBR forecast set to deliver some Budget day fiscal cheer for Chancellor, says EY
The Chancellor is set to receive a rare piece of good news on Budget day as the Office for Budget Responsibility’s (OBR) forecast is expected to reveal lower borrowing projections and stronger GDP growth, according to the EY ITEM Club Budget preview.
Residents’ views sought on ambitious vision for improving community facilities
Cambridge City Council is asking for the views of local people on its draft proposals for an ambitious vision for council-owned community facilities and the services they provide.
Horizon Discovery launches Multiplex I cfDNA Reference Standard set in Synthetic Plasma
Horizon Discovery Group plc, the world leader in the application of gene editing technologies including molecular reference standards, today announces the launch of its first HDx™ cfDNA (cell-free DNA) Reference Standard in Synthetic Plasma.
Consultation considers technical changes to auto enrolment process
A consultation has been published, looking at making two changes to the automatic enrolment process. The changes are for new employers due to become subject to automatic enrolment duties during 2017.
£25,000 award will make a splash for young hospice users in East Anglia
East Anglia’s Children’s Hospices (EACH) has secured £25,000 to refurbish its hydrotherapy pool in Milton, after winning a national award.
Industrial strategy: how it relates to the Cambridge commercial property market
Commenting on the government's Industrial Strategy green paper issued last month, Philip Woolner, head of Commercial Agency at Cheffins, explains how he believes it will relate to Cambridge and the commercial property market.
First British robotics seed fund launches
High Growth Robotics Limited, based at Adastral Park, Martlesham Heath near Ipswich, has announced the launch of the British Robotics Seed Fund – the first investment fund specialising in UK-based robotics start-ups.
Startups urged to enter EDF Pulse Awards
Leading energy company EDF seeks applications from Cambridge organisations for the 2017 edition of its open innovation competition EDF Pulse, aimed at innovative European startups in smart city, smart home, smart business and smart health.
Keep your start-up costs low with a virtual office
Allia Future Business Centre explains why a virtual office is a good place to build a start-up.
UK’s first Agile for Embedded Conference takes place in May
Feabhas, the UK’s leading independent provider of embedded software development training and ARM Approved Training Centre, announces it is holding the UK’s first Agile for Embedded Conference on 3 May at Easthampstead Park, Berkshire.
Contamac Ltd announces FDA clearance of Tangible Hydra-PEG™
Contamac Ltd, manufacturer of the Optimum® line of GP contact lens materials, is pleased to announce the FDA clearance of Tangible Hydra-PEG.
State-of-the-art conference facilities launch this spring at Jesus College
A Cambridge College is celebrating the imminent completion of its new state-of-the-art conference facilities.
Coal, fuel of the future
Coal will continue to be a major part of the energy mix for decades to come, but we need to use it more efficiently, suggests The Scientific Alliance.
Daniel Zeichner MP discusses future of dementia research with leading charity
Protecting the future of dementia research in a post-Brexit Britain was on the agenda when Cambridge MP Daniel Zeichner visited Alzheimer’s Research UK this week.
Cambridge startup aims to disrupt assisted living technology market
A new startup, based in the heart of Cambridge, is developing an innovative technology platform with the potential to revolutionise at-home care for older people in the UK.
‘Thinking Human’ by Julian Dixon features in pharmaceuticals magazine
Team Consulting's Director of Human Factors, Julian Dixon, has had an article published in industry journal, Pharmaceutical Manufacturing and Packing Sourcer. Julian’s article discusses how, through small-scale studies and human factor analysis, better inhalers can be developed that are simple and easy to use.
Share purchase on planned retirement
Share purchase arrangements on retirement are generally left out of business succession arrangements for shareholders, such as those providing for purchase on death or critical illness, since the matter of funding for such an arrangement is principally an investment issue and far more expensive than funding for purchase on (insurable) death or critical illness.
US2U Consulting shares its thoughts on Jugaad Innovation
US2U Consulting shares its thoughts on a new business concept sweeping the West.
Lynparza meets primary endpoint in Phase III trial in BRCA-mutated metastatic breast cancer
AstraZeneca’s breast cancer treatment, Lynparza (olaparib), provided a statistically-significant improvement in progression-free survival compared to chemotherapy in the first positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer.
Law firm staff get on their bikes for veterans in Tour de Hewitsons
Staff at law firm Hewitsons will swap their suits for lycra to complete a gruelling two-day charity bike ride.